Peter Redfield Joins DSMB
Peter Redfield has been invited to be a member of the Data and Safety Monitoring Board (DSMB) for the therapeutic clinical trial: “Efficacy of favipiravir in reducing mortality in adults at early stage of Eboal virus Disease in Guinea: a … Read more